long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
Published 1 month ago • 46 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:56
ongoing and future trials in mpn-ap/bp
-
1:37
the limited prognostic value of dflc in systemic al amyloidosis
-
2:23
new causenta #health #technology - arp wave overiview
-
1:49
drop bio health - new pathways for personalised healthcare
-
3:03
immunohistochemistry: h3k27m
-
0:53
dr. oh on the sequencing of new therapies for prostate cancer
-
1:26
mechanism of successful fecal microbiota transplantation in pouchitis
-
1:07:23
updates in als/mnd 2023: challenges and opportunities by dr. jeffrey rosenfeld
-
59:24
rebuilding what we've lost in covid: a perspective from the icu
-
1:01:59
the downslope of the omicron surge, and what to do as we turn the corner
-
54:00
rural health matters rfd broadcast on october 16, 2023
-
0:32
agem - local and sustained delivery of therapeutic agents to the tumour microenvironment
-
3:31
fda d.i.s.c.o. burst edition: fda approval of omisirge (omidubicel-onlv) to reduce time to neutro...
-
48:53
update on afm in 2020
-
1:06:32
oh-my-cron! there's a treatment available now!
-
0:55
how are the ehr regulations burdening healthcare?
-
1:03:23
the new “endemic phase” and a vaccine update
-
1:42
program update | my story
-
1:35
update on covid-19 variant of concern omicron
-
2:20
gov. beshear, mayor fischer attend 'blessing of the hands' ceremony at mary & elizabeth hospital
-
57:40
infection, immunity. and faod
-
1:25:03
community updates in vaccine research and clinical care